×
0 0 0 0 0 0 0 0
Stockreport

DrugDev Introduces Consent Engineering, the Clinical Trials Industry's First Truly SaaS Solution for Creating, Managing and Automating Informed Patient Consent In-House

IQVIA HOLDINGS INC (IQV)  More Company Research Source: PR Web
Last iqvia holdings inc earnings: 10/22 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.iqvia.com
PDF PHILADELPHIA, and LONDON, UK (PRWEB) February 14, 2018 Today at the 2018 SCOPE Summit for Clinical Operations Executives, DrugDev (an IQVIA company) unveiled the industry's first truly SaaS solution for electronic patient informed consent. Consent Engineering, the latest addition to the DrugDev Spark™ clinical operations suite, provides all the proven benefits of standard eConsent with the added ability for sponsors and CROs to develop robust and scalable consent systems without having to rely on external providers. For the first time, Consent Engineering on DrugDev Spark gives study teams the tools, training and best practice resources they need to create, manage and automate consent solutions in-house. This new ability significantly streamlines the time and cost of development and implementation, enabling sponsors and CROs to bring the proven benefits of eConsent to millions more patients worldwide.eConsent systems already are transforming patient satisfaction and retention, study [Read more]

IMPACT SNAPSHOT EVENT TIME: IQV
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
IQV alerts
from News Quantified
Opt-in for
IQV alerts

from News Quantified
Opt-in for
IQV alerts

from News Quantified